Carregant...

Sialidase-Based Anti-Influenza Virus Therapy Protects Against Secondary Pneumococcal Infection

BACKGROUND: DAS181 (Fludase(®)) is a sialidase fusion protein in clinical development as a broad-spectrum anti-influenza virus (IFV) therapeutics. Previous reports by others raised the concern that desialylation of airway epithelium might increase the susceptibility to Streptococcus pneumoniae infec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hedlund, Maria, Aschenbrenner, Laura M., Jensen, Kellie, Larson, Jeffrey L., Fang, Fang
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874251/
https://ncbi.nlm.nih.gov/pubmed/20170378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/651170
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!